INIS
accumulation
5%
angiotensin
7%
animals
10%
attenuation
14%
coronaviruses
39%
cysteine
6%
diseases
8%
enzymes
7%
fever
30%
genes
18%
genetics
5%
glycoproteins
20%
growth
5%
guinea pigs
7%
hearings
5%
host
25%
human cells
5%
humans
22%
interferon
22%
lethals
7%
losses
6%
messenger-rna
9%
mice
21%
mutants
5%
mutations
17%
particles
7%
pathogenesis
18%
pattern recognition
7%
precursor
5%
proteins
56%
receptors
15%
residues
7%
rna
22%
strains
20%
vaccines
22%
virulence
8%
viruses
100%
Immunology and Microbiology
Arenaviridae
18%
Attenuation
14%
Cells
29%
Coronavirinae
12%
Development
9%
Fever
7%
Gel Permeation Chromatography
12%
Gene
8%
Gene Expression
8%
Glycoprotein
21%
Glycosylation
6%
Growth
5%
Hemorrhagic Fever
18%
Host
21%
Human Cell
5%
Innate Immune System
7%
Interferon Type I
20%
Junin Virus
22%
Lassa Virus
11%
Machupo Virus
20%
Mouse
18%
Mutant
5%
New World Arenavirus
14%
Pattern Recognition Receptor
7%
Precursor
5%
RIG-I
6%
SARS Coronavirus
31%
Sendai Virus
14%
Vaccine Efficacy
19%
Viral Disease
19%
Viral Replication
10%
Virulence
10%
Virus
33%
Virus-Like Particle
5%
Wild Type
5%
Keyphrases
Accessory Protein
5%
Arenavirus
14%
Attenuation
8%
Bolivian Hemorrhagic Fever
5%
Glycoprotein
11%
Highly Pathogenic
9%
Junin Virus
9%
Lassa Fever
8%
Lassa Virus
11%
Machupo Virus
17%
New World Arenavirus
10%
Sendai Virus
7%
Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
7%
Virus
8%
Virus Infection
7%